TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.0160nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.0350nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.0500nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.0700nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 0.0880nM ΔG°: -59.7kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.0980nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.134nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.138nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.138nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.152nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 0.160nM ΔG°: -58.2kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.163nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.255nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 0.290nM ΔG°: -56.6kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.310nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.311nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 0.330nM ΔG°: -56.3kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.353nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.359nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.739nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 0.740nM ΔG°: -54.2kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.75nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.804nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.861nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Dainippon Sumitomo Pharma Co., Ltd.
Curated by ChEMBL
Affinity DataKi: 0.931nMAssay Description:Inhibition of HIV1 proteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 1.40nM ΔG°: -52.6kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 2.24nM ΔG°: -51.4kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 5.14nM ΔG°: -49.2kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 8.91nM ΔG°: -47.8kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 21.7nM ΔG°: -45.5kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Japan Energy Corporation
Japan Energy Corporation
Affinity DataKi: 24.9nM ΔG°: -45.1kJ/molepH: 6.0 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Substrates and cleavage fragments...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 59nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
TargetLong-chain fatty acid transport protein 1(Mus musculus)
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 91nMAssay Description:Inhibition of mouse recombinant FATP1 acyl-coA synthetase activity using [14C]oleic acid as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 91nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
TargetLong-chain fatty acid transport protein 1(Homo sapiens (Human))
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of human recombinant FATP1 acyl-coA synthetase activity using [14C]oleic acid as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 130nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Inhibition of recombinant human HSL expressed in baculovirus infected sf9 cells using PNPB as substrate after 5 mins by spectrophotometric methodMore data for this Ligand-Target Pair
TargetLong-chain fatty acid transport protein 1(Homo sapiens (Human))
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of human recombinant FATP1 acyl-coA synthetase activity using [14C]oleic acid as substrateMore data for this Ligand-Target Pair
TargetLong-chain fatty acid transport protein 1(Mus musculus)
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Daiichi Sankyo Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of mouse recombinant FATP1 acyl-coA synthetase activity using [14C]oleic acid as substrateMore data for this Ligand-Target Pair